Position in XFOR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$541,087
+$87,659 QoQ
Shares Held
131,014
+15.6% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in XFOR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Palumbo Wealth Management LLC holds $15,072,882 across 31 Biotechnology names. XFOR ranks #15 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
10,360 | $869,411 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
37,183 | $868,594 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
22,888 | $762,628 | |
| 4 | DSGN |
Design Therapeutics, Inc.
|
71,408 | $759,781 | |
| 5 | NVAX |
Novavax Inc
|
92,111 | $749,783 | |
| 6 | NKTR |
Nektar Therapeutics
|
10,173 | $731,947 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
37,966 | $717,557 | |
| 8 | IMNM |
Immunome Inc.
|
32,051 | $700,955 |
All Filings in XFOR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $541,087 | 131,014 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $453,428 | 113,357 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $326,018 | 95,327 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||